Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma
NCT05549167Phase 3Recruiting
- Sponsor
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
- Start
- May 2022
- Primary completion
- Sep 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in juvenile nasopharyngeal angiofibroma (JNA), sponsored by Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. Started May 2022; status: recruiting.
02
Drugs
sirolimus
03
Conditions
juvenile nasopharyngeal angiofibroma (JNA)
Beyond the preview
Go deeper on NCT05549167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05549167.